Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Efficacy of Porcine Placental Extracellular Matrix Augmented Wound Care Against Standard Wound Care for the Management of Diabetic Foot Ulcers: A Multi-center, Prospective, Observer-blinded, Randomized Controlled Clinical Trial.

NCT06616844 is registered in ClinicalTrials.gov with ConvaTec Inc. as lead sponsor.

NCT NCT06616844
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06616844 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Efficacy of Porcine Placental Extracellular Matrix Augmented Wound Care Against Standard Wound Care for the Management of Diabetic Foot Ulcers: A Multi-center, Prospective, Observer-blinded, Randomized Controlled Clinical Trial.
Lead sponsor
ConvaTec Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
February 12, 2025
Completion date
January 31, 2028
Enrollment
235 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

ulcer, wound heal